Publication Cover
Chronobiology International
The Journal of Biological and Medical Rhythm Research
Volume 34, 2017 - Issue 5
574
Views
36
CrossRef citations to date
0
Altmetric
Original Articles

Worsening of rest-activity circadian rhythm and quality of life in female breast cancer patients along progression of chemotherapy cycles

, &
Pages 609-623 | Received 18 Oct 2016, Accepted 21 Jan 2017, Published online: 16 Feb 2017

References

  • Aaronson NK, Ahmedzai S, Bergman B, et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 85:365–76.
  • Ahles TA, Saykin AJ, Furstenberg CT, et al. (2005). Quality of life of long-term survivors of breast cancer and lymphoma treated with standard-dose chemotherapy or local therapy. J Clin Oncol. 23:4399–405.
  • Alawadi SA, Ohaeri JU. (2009). Health related quality of life of Kuwaiti women with breast cancer: A comparative study using the EORTC quality of life questionnaire. BMC Cancer. 9:222–31.
  • Alder J, Zanetti R, Wight E, et al. (2008). Sexual dysfunction after premenopausal stage I and II breast cancer: Do androgens play a role? J Sex Med. 5:1898–906.
  • Alves Nogueira Fabro E, Bergmann A, do Amaral E Silva B, et al. (2012). Post-mastectomy pain syndrome: Incidence and risks. Breast. 21:321–5.
  • Ancoli-Israel S, Liu L, Marler MR, et al. (2006). Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer. 14:201–9.
  • Ancoli-Israel S, Liu L, Rissling M, et al. (2014). Sleep, fatigue, depression, and circadian activity rhythms in women with breast cancer before and after treatment: A 1-year longitudinal study. Support Care Cancer. 22:2535–45.
  • Arbuckle RB, Huber SL, Zacker C. (2000). The consequences of diarrhea occurring during chemotherapy for colorectal cancer: A retrospective study. Oncologist. 5:250–9.
  • Arnold RJ, Gabrail N, Raut M, et al. (2005). Clinical implications of chemotherapy-induced diarrhea in patients with cancer. J Support Oncol. 3:227–32.
  • Aschoff J. (1965). Circadian rhythms in man. A self-sustained oscillator with an inherent frequency underlies human 24-hour periodicity. Science. 148:1427–32.
  • Aschoff J. (1994). Naps as integral parts of the wake time within the human sleep-wake cycle. J Biol Rhythms. 9:145–55.
  • Batchelor D. (2001). Hair and cancer chemotherapy: Consequences and nursing care–a literature study. Eur J Cancer Care. 10:147–63.
  • Berger AM, Gerber LH, Mayer DK. (2012). Cancer-related fatigue: Implications for breast cancer survivors. Cancer. 118:2261–9.
  • Browall M, Ahlberg K, Karlsson P, et al. (2008). Health related quality of life during adjuvant treatment for breast cancer among postmenopausal women. Eur J Oncol Nurs. 12:180–9.
  • Carpenter JS, Elam JL, Ridner SH, et al. (2004). Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncol Nurs Forum. 31:591–8.
  • Cascinu S, Barni S, Labianca R, et al. (1997). Evaluation of factors influencing 5-fluorouracil-induced diarrhea in colorectal cancer patients. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) study. Support Care Cancer. 5:314–7.
  • Cash E, Sephton SE, Chagpar AB, et al. (2015). Circadian disruption and biomarkers of tumor progression in breast cancer patients awaiting surgery. Brain Behav Immun. 48:102–14.
  • Cherepanov D, Palta M, Fryback DG, et al. (2011). Gender differences in multiple underlying dimensions of health-related quality of life are associated with sociodemographic and socioeconomic status. Med Care. 49:1021–30.
  • Cigler T, Isseroff D, Fiederlein B, et al. (2015). Efficacy of scalp cooling in preventing chemotherapy-induced alopecia in breast cancer patients receiving adjuvant docetaxel and cyclophosphamide chemotherapy. Clin Breast Cancer. 15:332–44.
  • Cleeland CS, Janjan NA, Scott CB, et al. (2000). Cancer pain management by radiotherapists: A survey of radiation therapy oncology group physicians. Int J Radiat Oncol Biol Phys. 47:203–8.
  • Couceiro TC, Menezes TC, Valênça MM. (2009). Post-mastectomy pain syndrome: The magnitude of the problem. Rev Bras Anestesiol. 59:358–65.
  • Davis S, Mirick DK, Stevens RG. (2001). Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst. 93:1557–62.
  • Dibner C, Schibler U, Albrecht U. (2010). The mammalian circadian timing system: Organization and coordination of central and peripheral clocks. Annu Rev Physiol. 72:517–49.
  • Dranitsaris G, Lacouture ME. (2014). Development of prediction tools for diarrhea and rash in breast cancer patients receiving lapatinib in combination with capecitabine. Breast Cancer Res Treat. 147:631–8.
  • Duffy JF, Kronauer RE, Czeisler CA. (1996). Phase shifting human circadian rhythms: Influence of sleep timing, social contact and light exposure. J Physiol. 495:289–97.
  • El-Sharkawi FM, Sakr MF, Atta HY, Ghanem HM. (1997). Effect of different modalities of treatments on the quality of life of breast cancer patients in Egypt. East Mediterr Health J. 3:68–81.
  • Engle J, Kerr J, Schlesinger-raab A, et al. (2003). Predictors of quality of life of breast cancer patients. Acta Oncologica. 42:710–8.
  • Fan HG, Houédé-Tchen N, Yi QL, et al. (2005). Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol. 23:8025–32.
  • Fayers PM, Aaronson NK, Bjordal K, et al. (2001). On behalf of the EORTC Quality of Life Group. The EORTC QLQ-C30 Scoring Manual. 3rd edition. Brussels: EORTC.
  • Filipski E, Delaunay F, King VM, et al. (2004). Effects of chronic jet lag on malignant growth in mice. Cancer Res. 64:7879–85.
  • Filipski E, King VM, Li X, et al. (2002). Host circadian clock as a control point in tumor progression. J Natl Cancer Inst. 94:690–7.
  • Fiorentino L, Ancoli-Israel S. (2006). Insomnia and its treatment in women with breast cancer. Sleep Med Rev. 10:419–29.
  • Fortner BV, Stepanski EJ, Wang SC, et al. (2002). Sleep and quality of life in breast cancer patients. J Pain Symptom Manage. 24:471–80.
  • Friedrichs K, Carstensen MH. (2014). Successful reduction of alopecia induced by anthracycline and taxane containing adjuvant chemotherapy in breast cancer - clinical evaluation of sensor-controlled scalp cooling. SpringerPlus. 3:500.
  • Garcia SN, Jacowski M, Castro GC, et al. (2015). Quality of life domains affected in women with breast cancer. Rev Gaúcha Enferm. 36:89–96.
  • Given B, Given C, Azzouz F, Stommel M. (2001). Physical functioning of elderly cancer patients prior to diagnosis and following initial treatment. Nurs Res. 50:222–32.
  • Grant M, McMullen CK, Altschuler A, et al. (2011). Gender differences in quality of life among long-term colorectal cancer survivors with ostomies. Oncol Nurs forum. 38:587–96.
  • Grassi L, Berardi MA, Ruffilli F, et al. (2015). Role of psychosocial variables on chemotherapy-induced nausea and vomiting and health-related quality of life among cancer patients: A European study. Psychother Psychosom. 84:339–47.
  • Grem JL, Shoemaker DD, Patrelli NJ, Douglass HO Jr. (1987). Severe life-threatening toxicities observed in study using leucovorin with 5-fluorouracil. J Clin Oncol. 5:1704–12.
  • Grimison PS, Stockler MR. (2007). Quality of life and adjuvant systemic therapy for early-stage breast cancer. Expert Rev Anticancer Ther. 7:1123–34.
  • Gupta S, Pati AK. (1992). Data analysis methodology in chronobiological studies. J Parasitol Appl Anim Bio. 1:151–63.
  • Hansen J. (2006). Risk of breast cancer after night- and shift work: Current evidence and ongoing studies in Denmark. Cancer Causes Control. 17:531–7.
  • Harirchi I, Montazeri A, Bidokhti FZ, et al. (2012). i Sexual function in breast cancer patients: A prospective study from Iran. J Exp Clin Cancer Res. 31:20.
  • Härtl K, Janni W, Kästner R, et al. (2003). Impact of medical and demographic factors on long-term quality of life and body image of breast cancer patients. Ann Oncol. 7:1064–71.
  • Härtl K, Schennach R, Müller M, et al. (2010). Quality of life, anxiety, and oncological factors: A follow-up study of breast cancer patients. Psychosomatics. 51:112–23.
  • Hastings MH, Reddy AB, Maywood ES. (2003). A clockwork web: Circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci. 4:649–61.
  • Haus E. (2009). Chronobiology in oncology. Int J Radiat Oncol Biol Phys. 73:3–5.
  • Hofman M, Ryan JL, Figueroa-Moseley CD, et al. (2007). Cancer-related fatigue: The scale of the problem. Oncologist. 12:4–10.
  • Hogan CM. (1998). The nurse’s role in diarrhea management. Oncol Nurs Forum. 25:879–86.
  • Honma K, Honma S, Nakamura K, et al. (1995). Differential effects of bright light and social cues on reentrainment of human circadian rhythms. Am J Physiol. 268:R528–35.
  • Hopwood P, Haviland J, Mills J, et al. (2007). The impact of age and clinical factors on quality of life in early breast cancer: An analysis of 2208 women recruited to the UK START Trial (Standardisation of Breast Radiotherapy Trial). Breast. 3:241–51.
  • Innominato PF, Giacchetti S, Bjarnason GA, et al. (2012). Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancer. Int J Cancer. 131:2684–92.
  • Innominato PF, Focan C, Gorlia T, et al. (2009). Circadian rhythm in rest and activity: A biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. Cancer Res. 69:4700–7.
  • Kállay É, Dégi CL, Vincze AE. (2007). Dysfunctional attitudes, depression and quality of life in a sample of Romanian Hungarian cancer patients. J Cogn Behav Psychot. 7: 95–106.
  • Kayl AE, Meyers CA. (2006). Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients. Curr Opin Obstet Gynecol.18:24–8.
  • Komen MMC, Smorenburg CH, van den Hurk CJG, Nortier JWR. (2013). Factor influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia. Oncologist. 18:885–91.
  • Kronauer RE, Czeisler CA, Pilato SF, et al. (1982). Mathematical model of the human circadian system with two interacting oscillators. Am J Physiol. 242:R3–17.
  • Lehto US, Ojanen M, Kellokumpu-Lehtinen P. (2005). Predictors of quality of life in newly diagnosed melanoma and breast cancer patients. Ann Oncol. 16:805–16.
  • Lévi F, Okyar A, Dulong S, et al. (2010). Circadian timing in cancer treatments. Annu Rev Pharmacol Toxicol. 50:377–421.
  • Lévi F, Dugué PA, Innominato P, et al. (2014). Wrist actimetry circadian rhythm as a robust predictor of colorectal cancer patients survival. Chronobiol Int. 31:891–900.
  • Levin RD, Daehler MA, Grutsch JF, et al. (2005). Circadian function in patients with advanced non-small-cell lung cancer. Br J Cancer. 93:1202–8.
  • Li XM, Vincenti M, Lévi F. (2002). Pharmacological effects of vinorelbine on body temperature and locomotor activity circadian rhythms in mice. Chronobiol Int. 19:43–55.
  • Lindley C, Vasa S, Sawyer WT, Winer EP. (1998). Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. J Clin Oncol. 16:1380–7.
  • Littner M, Kushida CA, Anderson WM, et al. (2003). Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: An update for 2002. Sleep. 26:337–41.
  • Liu L, Marler MR, Parker BA, et al. (2005). The relationship between fatigue and light exposure during chemotherapy. Support Care Cancer. 13:1010–7.
  • Liu L, Rissling M, Neikrug A, et al. (2013). Fatigue and circadian activity rhythms in breast cancer patients before and after chemotherapy: A controlled study. Fatigue. 1:12–26.
  • Lôbo SA, Fernandes AFC, Almeida PC, et al. (2014). Quality of life in women with breast cancer undergoing chemotherapy. Acta Paul Enferm. 27:554–9.
  • Manandhar S, Shrestha DS, Taechaboonsermsk P, et al. (2014). Quality of life among breast cancer patients undergoing treatment in national cancer centers in Nepal. Asian Pac J Cancer Prev. 15:9753–7.
  • Mejdahl MK, Andersen KG, Gärtner R, et al. (2013). Persistent pain and sensory disturbances after treatment for breast cancer: Six year nationwide follow-up study. BMJ. 346:f1865.
  • Meyers CA, Abbruzzese JL. (1992). Cognitive functioning in cancer patients: Effect of previous treatment. Neurology. 42:434–6.
  • Meyers CA. (2008). How chemotherapy damages the central nervous system. J Biol. 7:11–3.
  • Montazeri A, Vahdaninia M, Harirchi I, et al. (2008). Quality of life in patients with breast cancer before and after diagnosis: An eighteen months follow-up study. BMC Cancer. 8:330–6.
  • Morgenthaler TI, Lee-Chiong T, Alessi C, et al. (2007). Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders: An American Academy of Sleep Medicine report. Sleep. 30:1445–59.
  • Mormont MC, Waterhouse J, Bleuzen P, et al. (2000). Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res. 6:3038–45.
  • Mormont MC, Waterhouse J. (2002). Contribution of the rest-activity circadian rhythm to quality of life in cancer patients. Chronobiol Int. 19:313–23.
  • Morrow GR, Andrews PL, Hickok JT, et al. (2002). Fatigue associated with cancer and its treatment. Support Care Cancer. 10:389–98.
  • Natale V, Innominato PF, Boreggiani M, et al. (2015). The difference between in bed and out of bed activity as a behavioral marker of cancer patients: A comparative actigraphic study. Chronobiol Int. 32:925–33.
  • Nelson W, Tong YL, Lee JK, Halberg F. (1979). Methods for Cosinor-rhythmometry. Chronobiologia. 6:305–23.
  • Ortiz-Tudela E, Innominato PF, Rol MA, et al. (2016). Relevance of internal time and circadian robustness for cancer patients. BMC Cancer. 16:285.
  • Ortiz-Tudela E, Iurisci I, Beau J, et al. (2014). The circadian rest-activity rhythm, a potential safety pharmacology endpoint of cancer chemotherapy. Int J Cancer. 134:2717–25.
  • Paganini-Hill A, Clark LJ. (2000). Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen. Breast Cancer Res Treat. 64:165–76.
  • Pandey M, Thomas BC, SreeRekha P, et al. (2005). Quality of Life determinants in women with breast cancer undergoing treatment with curative intent. World J Surg Oncol. 3:63–70.
  • Parganiha A, Taj S, Chandel P, et al. (2014). Effect of hospitalization on rest-activity rhythm and quality of life of cancer patients. IJEB. 52:549–58.
  • Park B-W, Lee S, Lee AR, et al. (2011). Quality of life differences between younger and older breast cancer patients. J Breast Cancer. 14:112–8.
  • Pati AK, Parganiha A, Kar A, et al. (2006). Implications of the study of rest-activity circadian rhythm in head and neck cancer patients. Biol Rhythm Res. 37:497–505.
  • Pati AK, Parganiha A, Kar A, et al. (2007). Alterations of the characteristics of the circadian rest-activity rhythm of cancer in-patients. Chronobiol Int. 24:1179–97.
  • Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol Int. 27:1911–29.
  • Pukkala E, Auvinen A, Wahlberg G. (1995). Incidence of cancer among Finnish airline cabin attendants, 1967–92. BMJ. 311:649–52.
  • Redeker NS, Lev EL, Ruggiero J. (2000). Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy. Sch Inq Nurs Pract. 14:275–90.
  • Reuben DB, Mor V. (1986). Dyspnea in terminally ill cancer patients. Chest. 89:234–6.
  • Richardson LC, Wang W, Hartzema AG, Wagner S. (2007). The role of health-related quality of life in early discontinuation of chemotherapy for breast cancer. Breast J. 13:581–7.
  • Roscoe JA, Morrow GR, Hickok JT, et al. (2002). Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment. Support Care Cancer. 10:329–36.
  • Rumble ME, Rose SL, White KH, et al. (2015). Circadian actigraphic rest-activity rhythms following surgery for endometrial cancer: A prospective, longitudinal study. Gynecol Oncol. 137:448–55.
  • Safaee A, Moghimi-Dehkordi B, Zeighami B, et al. (2008). Predictors of quality of life in breast cancer patients under chemotherapy. Indian J Cancer. 45:107–11.
  • Savard J, Liu L, Natajaran L, et al. (2009). Breast cancer patients have progressively impaired sleep-wake activity rhythms during chemotherapy. Sleep. 32:1155–60.
  • Schernhammer ES, Laden F, Speizer FE, et al. (2001). Rotating night shifts and risk of breast cancer in women participating in the nurses’ health study. J Natl Cancer Inst. 93:1563–8.
  • Schou I, Ekeberg Ø, Sandvik L, et al. (2005). Multiple predictors of health-related quality of life in early stage breast cancer. Data from a year follow-up study compared with the general population. Qual Life Res. 14:1813–23.
  • Souêtre E, Salvati E, Belugou JL, et al. (1989). Circadian rhythms in depression and recovery: Evidence for blunted amplitude as the main chronobiological abnormality. Psychiatry Res. 28:263–78.
  • Sprangers MA, Groenvold M, Arraras JI, et al. (1996). The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: First results from a three-country field study. J Clin Oncol. 14:2756–68.
  • Sultan A, Choudhary V, Parganiha A. (2014). Circadian rhythms in physical activity and energy expenditure in cancer patients. SAJEB. 4:327–37.
  • Taj S, Choudhary V, Parganiha A. (2013). Temporal profiles of physical activity and energy expenditure in cancer in-patients. Biol Rhythm Res. 44:219–35.
  • Teicher MH, Glod CA, Harper D, et al. (1993). Locomotor activity in depressed children and adolescents: I. Circadian dysregulation. J Am Acad Child Adolesc Psychiatry. 32:760–9.
  • Thomas JR, von-Gunten CF. (2003). Management of dyspnea. J Support Oncol. 1:23–32.
  • van den Hurk CJG, Mols F, Vingerhoets AJJM, Breed WPM. (2010). Impact of alopecia and scalp cooling on the well-being of breast cancer patients. Psychooncology. 19:701–9.
  • Van Someren EJW, Riemersma-van der Lek RF. (2007). Live to the rhythm, slave to the rhythm. Sleep Med Rev. 11:465–84.
  • Watters JM, Yau JC, O’Rourke K, et al. (2003). Functional status is well maintained in older women during adjuvant chemotherapy for breast cancer. Ann Oncol. 14:1744–50.
  • Wefel JS, Lenzi R, Theriault RL, et al. (2004). The cognitive sequelae of standard dose adjuvant chemotherapy in women with breast cancer: Results of a retrospective, randomized, longitudinal trial. Cancer. 100:2292–9.
  • Wehr TA, Sack D, Rosenthal N, et al. (1983). Circadian rhythm disturbances in manic-depressive illness. Fed Proc. 42:2809–14.
  • Wever RA. (1975). The circadian multi-oscillator system of man. Int J Chronobiol. 3:19–55.
  • Yeager CE, Olsen EA. (2011). Treatment of chemotherapy-induced alopecia. Dermatol Ther. 24:432–42.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.